SCHEMBL4154840

SCHEMBL4154840

N#Cc1cc(-c2nc3cncnc3s2)ccc1Oc1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 6/20 0.44
CYP19A1 P11511 2/20 0.41
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
PGGT1B P53609 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
AR P10275 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SCN9A Q15858 3/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PRKCQ Q04759 1/20 0.35
EGFR P00533 1/20 0.34
LCK P06239 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159263 0.89 SLC22A12 (0.41) SLC22A12FNTAFNTBPGGT1BCNR1
SCHEMBL2532037 0.89 ALDH1A1 (0.41) CYP19A1ALDH1A1SMN1; SMN2HPGDNPSR1
SCHEMBL4146990 0.89 SLC22A12 (0.46) SLC22A12CYP19A1FNTAFNTBPGGT1B
SCHEMBL4152592 0.86 ALDH1A1 (0.52) SLC22A12CYP19A1ALDH1A1SMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL4163294 0.85 ALDH1A1 (0.51) SLC22A12CYP19A1ALDH1A1SMN1; SMN2HPGD
SCHEMBL4149282 0.84 SLC22A12 (0.43) SLC22A12FNTAFNTBPGGT1BCNR1
SCHEMBL4141873 0.83 ALDH1A1 (0.38) SLC22A12ALDH1A1SMN1; SMN2HPGDNPSR1
SCHEMBL2535698 0.83 SLC22A12 (0.44) SLC22A12ALDH1A1HPGDNPSR1SCN9A
Potassium SCHEMBL4146433 0.82 ALDH1A1 (0.37) SLC22A12ALDH1A1SMN1; SMN2HPGDNPSR1
SCHEMBL4146427 0.82 ALDH1A1 (0.37) SLC22A12ALDH1A1SMN1; SMN2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3263109-B1 DRUG FOR PREVENTING AND/OR TREATING DEMENTIA NAT UNIV CORP TOTTORI UNIV (JP) 2020-06-17 EP claimed
US-20090149452-A1 XANTHINE OXIDASE INHIBITOR NIPPON CHEMIPHAR CO., LTD. (JP) 2009-06-11 US disclosed
EP-1911760-A1 XANTHINE OXIDASE INHIBITOR Nippon Chemiphar Co., Ltd. (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149452-A1 XANTHINE OXIDASE INHIBITOR XDH, PNPO, CBR1 SLC22A12 1556/4885CYP19A1 1670/4885FNTA 4027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.